Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Mar;4(2):127–132. doi: 10.1128/cdli.4.2.127-132.1997

Immunoregulatory effects of morphine on human lymphocytes.

M P Nair 1, S A Schwartz 1, R Polasani 1, J Hou 1, A Sweet 1, K C Chadha 1
PMCID: PMC170490  PMID: 9067644

Abstract

It is now well established that parenteral drug abuse is a significant risk factor for contracting human immunodeficiency virus type 1 (HIV-1) infection and subsequently developing AIDS. Earlier studies have shown that morphine can modulate various immune responses and therefore support the premise that morphine is a cofactor in susceptibility to and progression of HIV infection. Dysregulation of interferon (IFN) production, nonspecific apoptosis of T cells, and the immune response to soluble HIV gene products have been associated with potential mechanisms of pathogenesis in HIV disease. The present study was undertaken to examine the immunomodulatory role of morphine on HIV protein-induced lymphocyte proliferative responses, Sendai and Newcastle disease virus-induced alpha IFN (IFN-alpha) and IFN-beta production by lymphocytes and fibroblast cells, respectively, and induction of apoptosis of normal lymphocytes in vitro. Our results demonstrate that HIV protein-induced human lymphocyte proliferative responses were significantly inhibited by morphine in a dose-dependent manner. Furthermore, morphine significantly inhibited both IFN-alpha and IFN-beta production by normal lymphocytes and fibroblasts but induced apoptosis of normal lymphocytes. Inhibition of IFN-alpha production by morphine could be reversed by the opiate receptor antagonist naloxone. This suggests that the immunomodulatory effects of morphine are mediated through the opioid receptor. These studies support a role of morphine as a cofactor in the pathogenesis of HIV infection and describe some of the possible pathologic mechanisms which underlie the immunoregulatory effects of morphine.

Full Text

The Full Text of this article is available as a PDF (242.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ameisen J. C., Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today. 1991 Apr;12(4):102–105. doi: 10.1016/0167-5699(91)90092-8. [DOI] [PubMed] [Google Scholar]
  2. Ascaso R., Marvel J., Collins M. K., López-Rivas A. Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line. Eur J Immunol. 1994 Mar;24(3):537–541. doi: 10.1002/eji.1830240307. [DOI] [PubMed] [Google Scholar]
  3. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sekaly R. P., Finkel T. H. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med. 1992 Oct 1;176(4):1099–1106. doi: 10.1084/jem.176.4.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhargava H. N. Opioid peptides, receptors, and immune function. NIDA Res Monogr. 1990;96:220–233. [PubMed] [Google Scholar]
  5. Bryant H. U., Bernton E. W., Holaday J. W. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 1987 Oct 5;41(14):1731–1738. doi: 10.1016/0024-3205(87)90601-1. [DOI] [PubMed] [Google Scholar]
  6. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  7. Carr D. J., Serou M. Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology. 1995 Nov;31(1):59–71. doi: 10.1016/0162-3109(95)00033-6. [DOI] [PubMed] [Google Scholar]
  8. Chao C. C., Hu S., Molitor T. W., Zhou Y., Murtaugh M. P., Tsang M., Peterson P. K. Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther. 1992 Jul;262(1):19–24. [PubMed] [Google Scholar]
  9. Cheng J., Zhou T., Liu C., Shapiro J. P., Brauer M. J., Kiefer M. C., Barr P. J., Mountz J. D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994 Mar 25;263(5154):1759–1762. doi: 10.1126/science.7510905. [DOI] [PubMed] [Google Scholar]
  10. Chuang L. F., Killam K. F., Jr, Chuang R. Y. Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate. Biochem Biophys Res Commun. 1993 Sep 30;195(3):1165–1173. doi: 10.1006/bbrc.1993.2167. [DOI] [PubMed] [Google Scholar]
  11. Collins M. K., Marvel J., Malde P., Lopez-Rivas A. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med. 1992 Oct 1;176(4):1043–1051. doi: 10.1084/jem.176.4.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Curran J. W., Jaffe H. W., Hardy A. M., Morgan W. M., Selik R. M., Dondero T. J. Epidemiology of HIV infection and AIDS in the United States. Science. 1988 Feb 5;239(4840):610–616. doi: 10.1126/science.3340847. [DOI] [PubMed] [Google Scholar]
  13. Des Jarlais D. C., Friedman S. R., Stoneburner R. L. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis. 1988 Jan-Feb;10(1):151–158. doi: 10.1093/clinids/10.1.151. [DOI] [PubMed] [Google Scholar]
  14. Donahoe R. M. Drug abuse and AIDS: causes for the connection. NIDA Res Monogr. 1990;96:181–191. [PubMed] [Google Scholar]
  15. Donahoe R. M., Madden J. J., Hollingsworth F., Shafer D., Falek A. Morphine depression of T cell E-rosetting: definition of the process. Fed Proc. 1985 Jan;44(1 Pt 1):95–99. [PubMed] [Google Scholar]
  16. Duke R. C. Apoptosis in cytotoxic T lymphocytes and their targets. Semin Immunol. 1992 Dec;4(6):407–412. [PubMed] [Google Scholar]
  17. Emlen W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 1994 Apr 1;152(7):3685–3692. [PubMed] [Google Scholar]
  18. Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993 Nov 12;262(5136):1011–1018. doi: 10.1126/science.8235617. [DOI] [PubMed] [Google Scholar]
  19. Fauci A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988 Feb 5;239(4840):617–622. doi: 10.1126/science.3277274. [DOI] [PubMed] [Google Scholar]
  20. Garza H. H., Jr, Prakash O., Carr D. J. Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity. Int J Immunopharmacol. 1994 Dec;16(12):1061–1070. doi: 10.1016/0192-0561(94)90086-8. [DOI] [PubMed] [Google Scholar]
  21. Geber W. F., Lefkowitz S. S., Hung C. Y. Duration of interferon inhibition following single and multiple injections of morphine. J Toxicol Environ Health. 1977 Jan;2(3):577–582. doi: 10.1080/15287397709529458. [DOI] [PubMed] [Google Scholar]
  22. Geber W. F., Lefkowitz S. S., Hung C. Y. Role of spleen in the interferon-lowering action of morphine. Gen Pharmacol. 1976 Sep;7(4):255–258. doi: 10.1016/0306-3623(76)90084-7. [DOI] [PubMed] [Google Scholar]
  23. Gougeon M. L., Montagnier L. Apoptosis in AIDS. Science. 1993 May 28;260(5112):1269–1270. doi: 10.1126/science.8098552. [DOI] [PubMed] [Google Scholar]
  24. Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989 May 12;261(18):2677–2684. [PubMed] [Google Scholar]
  25. Hubbard R. L., Marsden M. E., Cavanaugh E., Rachal J. V., Ginzburg H. M. Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis. 1988 Mar-Apr;10(2):377–384. doi: 10.1093/clinids/10.2.377. [DOI] [PubMed] [Google Scholar]
  26. Itoh N., Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 1993 May 25;268(15):10932–10937. [PubMed] [Google Scholar]
  27. Kabelitz D., Pohl T., Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today. 1993 Jul;14(7):338–339. doi: 10.1016/0167-5699(93)90231-9. [DOI] [PubMed] [Google Scholar]
  28. Kinter A. L., Poli G., Fox L., Hardy E., Fauci A. S. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol. 1995 Mar 1;154(5):2448–2459. [PubMed] [Google Scholar]
  29. Kovacs J. A., Baseler M., Dewar R. J., Vogel S., Davey R. T., Jr, Falloon J., Polis M. A., Walker R. E., Stevens R., Salzman N. P. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med. 1995 Mar 2;332(9):567–575. doi: 10.1056/NEJM199503023320904. [DOI] [PubMed] [Google Scholar]
  30. Leonard R., Zagury D., Desportes I., Bernard J., Zagury J. F., Gallo R. C. Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection. Proc Natl Acad Sci U S A. 1988 May;85(10):3570–3574. doi: 10.1073/pnas.85.10.3570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Li C. J., Friedman D. J., Wang C., Metelev V., Pardee A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 1995 Apr 21;268(5209):429–431. doi: 10.1126/science.7716549. [DOI] [PubMed] [Google Scholar]
  32. Lorenzo P., Portolés A., Jr, Beneit J. V., Ronda E., Portolés A. Physical dependence to morphine diminishes the interferon response in mice. Immunopharmacology. 1987 Oct-Nov;14(2):93–99. doi: 10.1016/0162-3109(87)90033-6. [DOI] [PubMed] [Google Scholar]
  33. Lu Y. Y., Koga Y., Tanaka K., Sasaki M., Kimura G., Nomoto K. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J Virol. 1994 Jan;68(1):390–399. doi: 10.1128/jvi.68.1.390-399.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Maity R., Mukherjee R., Skolnick P. Morphine inhibits the development of allogeneic immune responses in mouse lymph node. Immunopharmacology. 1995 Mar;29(2):175–183. doi: 10.1016/0162-3109(94)00058-n. [DOI] [PubMed] [Google Scholar]
  35. Maneckjee R., Minna J. D. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 1994 Oct;5(10):1033–1040. [PubMed] [Google Scholar]
  36. McDonough R. J., Madden J. J., Falek A., Shafer D. A., Pline M., Gordon D., Bokos P., Kuehnle J. C., Mendelson J. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol. 1980 Dec;125(6):2539–2543. [PubMed] [Google Scholar]
  37. Merrill J. E., Chen I. S. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 1991 Jul;5(10):2391–2397. doi: 10.1096/fasebj.5.10.2065887. [DOI] [PubMed] [Google Scholar]
  38. Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 1992 Jul 10;257(5067):217–219. doi: 10.1126/science.1352911. [DOI] [PubMed] [Google Scholar]
  39. Nair M. P., Kumar N. M., Kronfol Z. A., Saravolatz L. A., Pottathil R., Greden J. F., Schwartz S. A. Selective effect of alcohol on cellular immune responses of lymphocytes from AIDS patients. Alcohol. 1994 Mar-Apr;11(2):85–90. doi: 10.1016/0741-8329(94)90048-5. [DOI] [PubMed] [Google Scholar]
  40. Nair M. P., Laing T. J., Schwartz S. A. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers. Clin Immunol Immunopathol. 1986 Jan;38(1):68–78. doi: 10.1016/0090-1229(86)90123-6. [DOI] [PubMed] [Google Scholar]
  41. Nair M. P., Pottathil R., Heimer E. P., Schwartz S. A. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6498–6502. doi: 10.1073/pnas.85.17.6498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Newell M. K., Haughn L. J., Maroun C. R., Julius M. H. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature. 1990 Sep 20;347(6290):286–289. doi: 10.1038/347286a0. [DOI] [PubMed] [Google Scholar]
  43. Okabe T., Takayanagi R., Imasaki K., Haji M., Nawata H., Watanabe T. cDNA cloning of a NGFI-B/nur77-related transcription factor from an apoptotic human T cell line. J Immunol. 1995 Apr 15;154(8):3871–3879. [PubMed] [Google Scholar]
  44. Pahwa S., Pahwa R., Good R. A., Gallo R. C., Saxinger C. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9124–9128. doi: 10.1073/pnas.83.23.9124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Peterson P. K., Gekker G., Hu S., Anderson W. R., Kravitz F., Portoghese P. S., Balfour H. H., Jr, Chao C. C. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol. 1994 Mar;50(2):167–175. doi: 10.1016/0165-5728(94)90043-4. [DOI] [PubMed] [Google Scholar]
  46. Peterson P. K., Gekker G., Schut R., Hu S., Balfour H. H., Jr, Chao C. C. Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv Exp Med Biol. 1993;335:181–188. doi: 10.1007/978-1-4615-2980-4_26. [DOI] [PubMed] [Google Scholar]
  47. Peterson P. K., Sharp B. M., Gekker G., Portoghese P. S., Sannerud K., Balfour H. H., Jr Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS. 1990 Sep;4(9):869–873. doi: 10.1097/00002030-199009000-00006. [DOI] [PubMed] [Google Scholar]
  48. Peterson P. K., Sharp B., Gekker G., Brummitt C., Keane W. F. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest. 1987 Sep;80(3):824–831. doi: 10.1172/JCI113140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Robinson W. E., Jr, Gorny M. K., Xu J. Y., Mitchell W. M., Zolla-Pazner S. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol. 1991 Aug;65(8):4169–4176. doi: 10.1128/jvi.65.8.4169-4176.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schweitzer C., Keller F., Schmitt M. P., Jaeck D., Adloff M., Schmitt C., Royer C., Kirn A., Aubertin A. M. Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res Virol. 1991 Mar-Jun;142(2-3):189–195. doi: 10.1016/0923-2516(91)90056-9. [DOI] [PubMed] [Google Scholar]
  51. Shirazi Y., Pitha P. M. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology. 1993 Mar;193(1):303–312. doi: 10.1006/viro.1993.1126. [DOI] [PubMed] [Google Scholar]
  52. Shoeman R. L., Young D., Pottathil R., Victor J., Conroy R. R., Crowl R. M., Coleman T., Heimer E., Lai C. Y., Ganguly K. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents. Anal Biochem. 1987 Mar;161(2):370–379. doi: 10.1016/0003-2697(87)90465-9. [DOI] [PubMed] [Google Scholar]
  53. Squinto S. P., Mondal D., Block A. L., Prakash O. Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells. AIDS Res Hum Retroviruses. 1990 Oct;6(10):1163–1168. doi: 10.1089/aid.1990.6.1163. [DOI] [PubMed] [Google Scholar]
  54. Terai C., Kornbluth R. S., Pauza C. D., Richman D. D., Carson D. A. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest. 1991 May;87(5):1710–1715. doi: 10.1172/JCI115188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Thomas P. T., Bhargava H. N., House R. V. Immunomodulatory effects of in vitro exposure to morphine and its metabolites. Pharmacology. 1995 Jan;50(1):51–62. doi: 10.1159/000139266. [DOI] [PubMed] [Google Scholar]
  56. Tyring S. K., Cauda R., Tumbarello M., Ortona L., Kennedy R. C., Chanh T. C., Kanda P. Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2. Viral Immunol. 1991 Spring;4(1):33–42. doi: 10.1089/vim.1991.4.33. [DOI] [PubMed] [Google Scholar]
  57. Virsik P. A., Bussiere J. L. Adjuvant effects on morphine-induced suppression of immune responses to MN rgp120/HIV-1 in mice. Adv Exp Med Biol. 1995;373:183–188. doi: 10.1007/978-1-4615-1951-5_25. [DOI] [PubMed] [Google Scholar]
  58. Vyakarnam A., McKeating J., Meager A., Beverley P. C. Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS. 1990 Jan;4(1):21–27. doi: 10.1097/00002030-199001000-00003. [DOI] [PubMed] [Google Scholar]
  59. Wain-Hobson S. AIDS. Virological mayhem. Nature. 1995 Jan 12;373(6510):102–102. doi: 10.1038/373102a0. [DOI] [PubMed] [Google Scholar]
  60. Yeager M. P., Colacchio T. A., Yu C. T., Hildebrandt L., Howell A. L., Weiss J., Guyre P. M. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 1995 Sep;83(3):500–508. doi: 10.1097/00000542-199509000-00008. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES